Drug profile · INN
eribulin
ERIBULIN DR.REDDY''S
eribulin (ERIBULIN DR.REDDY''S) is a tubulin inhibitor. Associated with Eisai Co.,.
EMA: approved TGA: approved Antineoplastic and immunomodulating agents (L01) L01XX41
Patents linked 3
Pipeline programs 12
News articles 1
Drug details — eribulin
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 3
- Programs
- 12
- Data quality
- 0.83
Quick answer
eribulin (ERIBULIN DR.REDDY''S) is a tubulin inhibitor. Associated with Eisai Co.,.
Key facts
INN eribulin
Brand ERIBULIN DR.REDDY''S
Mechanism Tubulin inhibitor
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XX41
Originator Eisai Co.,
Mechanism of action
Tubulin inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is eribulin?
eribulin (ERIBULIN DR.REDDY''S) is a tubulin inhibitor. Associated with Eisai Co.,.
What is the brand name for eribulin?
ERIBULIN DR.REDDY''S is a marketed brand name for eribulin. Check FDA Drugs@FDA for the current US label holder and prescribing information.